Home >Products> Medical Lab Instruments >Other Medical Lab Instruments> PharmaLegacy Laboratories (Shanghai) Co., Ltd will do lates
Medical Lab Instruments:  Microplate Readers / Plates Washers   Microbiological Analysis   Other Medical Lab Instruments  
PharmaLegacy Laboratories (Shanghai) Co., Ltd will do lates
Place of Origin:
China
Brand:
PharmaLegacy
Model:
YVSR202
Price:
1RMB
Hits:
491 
Updated:
8/31/2018
  • Product Detail
  • Company Profile

       

    PharmaLegacy Laboratories (Shanghai) Co., Ltd is a professional supplier which provides a variety of Rheumatoid arthritis Model, to provide customers withSuperior qualityRheumatoid arthritis Model ,DMPKand Rheumatoid arthritis Model and so on. Since the company had been established in Building 7, 388 Jialilue Road Zhangjiang High-Tech Park Pudong District Shanghai,Pudongxin District,City area,Shanghai,China, adhere to people-oriented ,and the quality of survival, to the credibility of development,our company have made an outstanding achievement.

       The advantage of PharmaLegacyLiver Fibrosis Modelx2a38631nis that it can provide more professional and thoughtful solutions timely and accurately according to the actual needs of customers.At the same time, Our company follow the latest developments on Business services,Medical service,Medical insurance, and establish long and steady partnership relation with many well-known enterprises in the same industry , to provide customers with the most professional, advanced Non-Human Primates Capability.Details:Rheumatoid arthritis model (RA) is a systemic inflammatory disorder characterized by chronic inflammation of the synovium, which over time results in damage to the joints, leading to pain and disability. It occurs in approximately 1% of adults, and approximately 2.5 times more women than men are affected. Immune factors involved in the progression of RA are mainly manufactured by CD4+ T cells, monocytes, macrophages, or fibroblasts. Cytokines produced by these cells such as tumor necrosis factor α (TNF-α) and interleukin-1 are the keys to the damaging cascade that ultimately triggers the production of matrix metalloproteinases and osteoclasts resulting in irreversible damage to soft tissues and bones.Understanding of molecular pathogenesis of rheumatoid arthritis model has enabled development of innovative agents to modulate specific components of the disease progress for early intervention or treatment. Various experimentally induced rheumatoid arthritis models have been used extensively as the mainstay for evaluation of those therapeutic candidates.

       PharmaLegacy always adheres to the corporate purpose: Sincere service, the pursuit of perfectionand advancing with the times,make progress together with51-100 people people, and go hand in hand to get innovation and a win-win situation. To get more information about Rheumatoid arthritis Model,, you can log in and look through PharmaLegacy official website:www.pharmalegacy.com

    bio-equip.cn
    PharmaLegacy Laboratories is a leading speciality pharmacology Contract Research Organization located in Shanghai Zhangjiang High-Tech Park, China. PharmaLegacy is equipped with a world-class facility, working to international pharmaceutical industrial standards. PharmaLegacy provides preclinical in vivo pharmacology efficacy services as well a therapeutic antibody discovery service program. Our state-of-the-art platforms include:· Pioneering work using CD34+ humanized mice that carry a human immune system, to test biologics for immuno-oncology therapeutic efficacy· An NHP platform for therapeutic biologics testing in a variety of immune diseases · An advanced antibody discovery platform based on single B cell antibody sequencing · An internationally recognized Bone/Orthopaedics platform to test both hard tissue disease therapeutic candidates and medical devicesPharmaLegacy offers a full range of preclinical pharmacology services for evaluating pharmacological effects of drug candidates in the areas of inflammation/auto-Immune diseases, lung injury, liver/metabolic diseases and oncology. Our NHP platform and CD34+ humanized mice models have helped dozens of clients with IND filings
Request Information
Request Information: yes no
Request Quotation: yes no
refresh

I agree to share my inquiry with the other matching suppliers.

Request Information

* Name:
Job Title:
* Tel:
Fax:
* E-mail:
Postcode:
Institution/Company:
Address:
* Country:
Request Information:
yes no
Request Quotation:
yes no
* Message:
* Verification Code:
refresh
I agree to share my inquiry to the other matching suppliers.